Antithrombotic therapy in ACS patients with atrial fibrillation in Japanese practice: STAR-ACS
STAR-ACS has found that the majority of patients with atrial fibrillation undergoing PCI for ACS in Japan today received DOACs as their anticoagulant of choice, with the number of prescriptions for antiplatelet agents decreasing over time, but the proportion of patients on three-drug antithrombotic therapy at two years was higher for patients who received warfarin than in those who received DOAC, as presented by Dr. Hiroshi Iwata of Juntendo University at the Late Breaking Cohort Studies session of the 87th Annual Scientific Meeting of the Japanese Circulation Society.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
